Loading...
Docoh

Stryker (SYK)

Stryker is one of the world's leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes.

Company profile

Ticker
SYK
Exchange
Website
CEO
Kevin Lobo
Employees
Incorporated
Location
Fiscal year end
SEC CIK
Subsidiaries
2Hip Holdings SAS • Aimago SA • Alcott Indemnity Company • Arrinex, Inc. • Berchtold + Fritz GmbH • Berchtold Consulting GmbH • Berchtold Corporation • Berchtold GmbH & Co. KG • Berchtold Holding Switzerland GmbH • BioMimetic Therapeutics USA, Inc. ...
IRS number
381239739

SYK stock data

Calendar

27 Jul 22
12 Aug 22
31 Dec 22
Quarter (USD) Jun 22 Mar 22 Dec 21 Sep 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD) Dec 21 Dec 20 Dec 19 Dec 18
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Cash burn rate (est.) Burn method: Change in cash Burn method: Operating income Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 1.04B 1.04B 1.04B 1.04B 1.04B 1.04B
Cash burn (monthly) 138M 99.75M (no burn) (no burn) (no burn) (no burn)
Cash used (since last report) 200.98M 145.28M n/a n/a n/a n/a
Cash remaining 843.02M 898.72M n/a n/a n/a n/a
Runway (months of cash) 6.1 9.0 n/a n/a n/a n/a

Beta Read what these cash burn values mean

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
2 Aug 22 Fletcher Robert S RSU Common Stock Grant Acquire A No No 0 2,343 0 2,343
1 Aug 22 James Andrew Pierce Common Stock Payment of exercise Dispose F No No 214.75 380 81.61K 38,791
1 Aug 22 James Andrew Pierce Common Stock Option exercise Acquire M No No 0 765 0 39,171
1 Aug 22 James Andrew Pierce RSU Common Stock Option exercise Dispose M No No 0 765 0 0
1 Aug 22 Spencer S Stiles Common Stock Payment of exercise Dispose F No No 214.75 334 71.73K 35,668
1 Aug 22 Spencer S Stiles Common Stock Option exercise Acquire M No No 0 765 0 36,002
1 Aug 22 Spencer S Stiles RSU Common Stock Option exercise Dispose M No No 0 765 0 0
3 Jun 22 Spencer S Stiles Common Stock Payment of exercise Dispose F No No 234.39 7,970 1.87M 35,237
3 Jun 22 Spencer S Stiles Common Stock Option exercise Acquire M No No 64.01 12,505 800.45K 43,207
3 Jun 22 Spencer S Stiles Employee Stock Option granted 02/13/2013 Common Stock Option exercise Dispose M No No 64.01 12,505 800.45K 0
75.3% owned by funds/institutions
13F holders Current Prev Q Change
Total holders 1626 1613 +0.8%
Opened positions 118 199 -40.7%
Closed positions 105 110 -4.5%
Increased positions 594 589 +0.8%
Reduced positions 610 511 +19.4%
13F shares Current Prev Q Change
Total value 76.09B 73.39B +3.7%
Total shares 284.74M 274.4M +3.8%
Total puts 1.32M 1.17M +13.0%
Total calls 1.08M 829.26K +29.7%
Total put/call ratio 1.2 1.4 -12.9%
Largest owners Shares Value Change
Vanguard 28.9M $7.73B +0.9%
BLK Blackrock 23.38M $6.25B -2.0%
TROW T. Rowe Price 20.16M $5.39B -4.7%
Greenleaf Trust 20.06M $5.36B -0.8%
Wellington Management 15.37M $4.11B +11.3%
STT State Street 13.82M $3.7B -0.7%
Capital Research Global Investors 10.4M $2.78B +5.1%
BK Bank Of New York Mellon 7.03M $1.88B -1.5%
Fundsmith 5.85M $1.56B NEW
BEN Franklin Resources 5.45M $1.46B -0.6%
Largest transactions Shares Bought/sold Change
Fundsmith 5.85M +5.85M NEW
First Western Trust Bank 4.05M +4.05M NEW
Norges Bank 0 -3.05M EXIT
Ontario Teachers Pension Plan Board 2.08M +2.08M +87902.2%
Wellington Management 15.37M +1.56M +11.3%
Fundsmith Investment Services 1.49M +1.49M NEW
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main 1.71M +1.41M +465.3%
WCM Investment Management 1.81M -1.27M -41.3%
AustralianSuper Pty 1.1M +1.1M NEW
TROW T. Rowe Price 20.16M -995.55K -4.7%

Financial report summary

?
Management Discussion
  • In 2021 we achieved reported net sales growth of 19.2%. Excluding the impact of acquisitions and divestitures, sales grew 12.6% in constant currency. We reported net earnings of $1,994 and net earnings per diluted share of $5.21. Excluding the impact of certain items, we achieved adjusted net earnings(1) of $3,474
  • and adjusted net earnings per diluted share(1) of $9.09 representing growth of 22.3%.
  • Effective December 31, 2021 we changed our reportable business segments to (i) MedSurg and Neurotechnology and (ii) Orthopaedics and Spine to align to our new internal reporting structure. Refer to Note 14 to our Consolidated Financial Statements for further information.

Content analysis

?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. freshman Good
New words: Alongside, Asia, competitive, conduct, delay, deliver, environment, establish, FDA, indefinitely, July, macroeconomic, motion, Pacific, paid, premium, pressure, raw, reinvested, reliance, reversal, settled, shipping, spot, sterilization, subsided, suffer, unable, unanticipated, unavailability, undistributed, unique, unwilling, validation, weakening
Removed: disciplined, duration, facilitate, ramp, recession, reduced, sensitive, slowdown, spending, working